CN101732638B - Chinese medicament for treating pulmonary tuberculosis - Google Patents

Chinese medicament for treating pulmonary tuberculosis Download PDF

Info

Publication number
CN101732638B
CN101732638B CN2010101024429A CN201010102442A CN101732638B CN 101732638 B CN101732638 B CN 101732638B CN 2010101024429 A CN2010101024429 A CN 2010101024429A CN 201010102442 A CN201010102442 A CN 201010102442A CN 101732638 B CN101732638 B CN 101732638B
Authority
CN
China
Prior art keywords
parts
chinese medicament
decoction
treating
pulmonary tuberculosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010101024429A
Other languages
Chinese (zh)
Other versions
CN101732638A (en
Inventor
沈信堂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010101024429A priority Critical patent/CN101732638B/en
Publication of CN101732638A publication Critical patent/CN101732638A/en
Application granted granted Critical
Publication of CN101732638B publication Critical patent/CN101732638B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicament for treating white plague, and aims to provide a Chinese medicament which is used for treating the white plague, and has quick response, good treatment effect, high cure rate and no side effect basically. The Chinese medicament for treating the white plague is prepared from the following raw materials in part by weight: 30 to 50 parts of Chinese mahonia leaf, 10 to 20 parts of ginkgo seed, 10 to 20 parts of sessile stemona root, 10 to 20 parts of bletilla, 10 to 20 parts of andrographis paniculata, 10 to 20 parts of beautiful millettia root and 10 to 20 parts of common selfheal fruit-spike; and the Chinese medicament is a decoction prepared by adding water into the seven raw materials for decoction and filtering residue. According to a formula, one dose is added with water and decocted into the decoction everyday; the decoction is taken by two to three times; and through clinical application, the Chinese medicament has satisfactory treatment effect on the white plague.

Description

A kind of Chinese medicine for the treatment of pulmonary tuberculosis
Technical field
The invention belongs to Chinese medicine, more specifically to a kind of Chinese medicine for the treatment of pulmonary tuberculosis.
Background technology
Pulmonary tuberculosis is the chronic infectious disease that is caused by tubercule bacillus.Pulmonary tuberculosis is modal a kind of in the tuberculosis.In 19th century, do not know to have how many people once to be seized relatives or friend by the deadly infectious disease of this mercilessness.Along with coming out one after another of medicines such as specific drug streptomycin, isoniazid, rifampicin, ethambutol, lunger's number is significantly reduced.Though 20th century multiple effective antibiotic and the generation of prophylactic agent the pulmonary tuberculosis case is worldwide reduced rapidly, but therefore lose vigilance, when on March 24th, 2003 " World Tuberculosis Prevention and Cure Day ", the numeral that " prevention tuberculosis " world action tissue is announced shows, the whole world still has 5000 people to die from tuberculosis every day at present, surpasses 8,000,000 and suffer from number lungy every year.In recent years because antibiotic abuse and treat lack of standardizationly makes large quantities of tuberculosis patients produce the drug resistance phenomenons.According to statistics, the resistant tuberculosis patient accounts for the 28%-41% of therapist sum first.This has just beaten alarm bell to people: tuberculosis is bad have been controlled, and there have 1/3 patient once to control to be bad, and the therapeutic alliance of life-time service Western medicine, it takes effect slowly, and the course of treatment is long, and side effect is big.In recent years again because deterioration of environment quality, the essential water of people's daily life, air, food etc. all have been subjected to industrial pollution, and people's resistivity has descended, and by airborne tuberculosis revivable gesture is arranged.
Summary of the invention
The Chinese medicine of the treatment pulmonary tuberculosis that the purpose of this invention is to provide a kind of instant effect, good effect, cure rate height and have no side effect substantially.
A kind of Chinese medicine for the treatment of pulmonary tuberculosis of the present invention, it is characterized in that making: Folium Mahoniae 30-50, Semen Ginkgo 10-20, Radix Stemonae 10-20, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-20, Herba Andrographitis 10-20, Millettia Speciosa 10-20 and Spica Prunellae 10-20 by the raw material of following weight parts, and described Chinese medicine is that above-mentioned 7 flavor raw materials decoct with water the decoction that the elimination slag becomes.
The pulmonary tuberculosis traditional Chinese medical science claims " pulmonary tuberculosis ", and the traditional Chinese medical science is thought lung tender dirty for void clearly, and " pulmonary tuberculosis " is that the consumptive disease worm is invaded in lung, and lung qi is impaired, and asthenic fire is burnt Tianjin and given birth to expectorant, and damage lung network is then spat blood." kill its worm first with exhausted basic, mend its void first with multiple its true unit " promptly proposed in bright " the medical science main story consumptive disease utmost point ".So its Therapeutic Principle is: 1. invigorating deficiency and tonifying vital QI: the pulmonary tuberculosis focus should be based on tonifying the lung gas, lung benefiting the moon at lung, and spleen is involved in prolonged illness, kidney two is dirty, and suitable training is unit very; 2. anti-consumptive disease worm extremely: the consumptive disease worm is the basic of the cause of disease, cures the disease and effects a permanent cure earlier, so need the anti-consumptive disease worm that kills.Among the we: Folium Mahoniae have the heat clearing away tonify deficiency, and the effect of relieving cough and resolving phlegm is controlled pulmonary tuberculosis hemoptysis, osteopyrexia and fever, and the lung heat clearing fire is arranged, and the effect of lung benefiting the moon again can detumescence and apocenosis, are the indispensable medicines of treatment lung disease.The Semen Ginkgo QI invigorating nourishes heart, the kidney tonifying YIN nourishing, and the cough-relieving relieving restlessness, slightly poisonous, utilizing mild toxicity to kill the consumptive disease worm is a kind of good medicine.The Pseudobulbus Bletillae (Rhizoma Bletillae) is ended lung blood, granulation promoting, detumescence effect, the kind lung disease of controlling.Herba Andrographitis has heat-clearing and toxic substances removing, removing heat from blood, detumescence effect.The lung moistening of Millettia Speciosa tonify deficiency, strong muscle is active.Spica Prunellae heat-clearing and toxic substances removing, hard masses softening and resolving, drive the stagnation resolvation tumor.Since the synergism of above-mentioned each medicine energy health invigorating, the resistance against diseases of regulating body.Use 12 routine patients, at 52~78 years old age, average 65 years old, treat 72~180 days (average course of treatment 140 days).Take the photograph sheet inspection and the inspection of expectorant bacterium through X-ray, wherein produce effects 6 examples (the focus scope absorbs more than 2/3, and the cavity is closed, and the expectorant bacterium is turned out cloudy); Effective 4 examples (the focus scope absorbs more than 2/3, and the cavity dwindles, and expectorant bacterium number reduces), total effective rate 83.3%, invalid 2 examples.After followed up a case by regular visits to 8 examples in 4 years, recur 1 example, the recurrence patient is overworked for curing the back, does not strengthen after treatment.Also very important according to clinical empirical summary more back after treatment.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Material name Embodiment 1 Embodiment 2 Embodiment 3 Embodiment 4 Embodiment 5
Folium Mahoniae 30 50 35 40 45
Semen Ginkgo 10 20 15 12 18
The Radix Stemonae 15 18 12 10 20
The Pseudobulbus Bletillae (Rhizoma Bletillae) 20 10 18 15 12
Herba Andrographitis 10 20 12 18 15
Millettia Speciosa 20 12 10 15 18
Spica Prunellae 18 20 12 15 10
According to decocting with water into decoction 1 dose of above-mentioned prescription every day, divide and take for 2-3 time, through clinical practice pulmonary tuberculosis there is satisfied curative effect.

Claims (1)

1. Chinese medicine for the treatment of pulmonary tuberculosis, it is characterized in that making: Folium Mahoniae 30-50, Semen Ginkgo 10-20, Radix Stemonae 10-20, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-20, Herba Andrographitis 10-20, Millettia Speciosa 10-20 and Spica Prunellae 10-20 by the raw material of following weight parts, and described Chinese medicine is that above-mentioned 7 flavor raw materials decoct with water the decoction that the elimination slag becomes.
CN2010101024429A 2010-01-22 2010-01-22 Chinese medicament for treating pulmonary tuberculosis Expired - Fee Related CN101732638B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101024429A CN101732638B (en) 2010-01-22 2010-01-22 Chinese medicament for treating pulmonary tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101024429A CN101732638B (en) 2010-01-22 2010-01-22 Chinese medicament for treating pulmonary tuberculosis

Publications (2)

Publication Number Publication Date
CN101732638A CN101732638A (en) 2010-06-16
CN101732638B true CN101732638B (en) 2011-06-01

Family

ID=42457006

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101024429A Expired - Fee Related CN101732638B (en) 2010-01-22 2010-01-22 Chinese medicament for treating pulmonary tuberculosis

Country Status (1)

Country Link
CN (1) CN101732638B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104906481A (en) * 2015-07-11 2015-09-16 陈四新 Preparation method for medicine for treating pulmonary tuberculous cavity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1814176A (en) * 2005-12-05 2006-08-09 杨雄志 Chinese medicine composition for treating phthisis and use thereof
CN101559186A (en) * 2009-05-27 2009-10-21 高春喜 Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1814176A (en) * 2005-12-05 2006-08-09 杨雄志 Chinese medicine composition for treating phthisis and use thereof
CN101559186A (en) * 2009-05-27 2009-10-21 高春喜 Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
乔富渠.肺结核的中医证治.《陕西中医》.1989,第10卷(第05期),235-236. *
康雁翔等.中西医结合治疗肺结核概况.《山西中医》.2008,第24卷(第02期),58-60. *

Also Published As

Publication number Publication date
CN101732638A (en) 2010-06-16

Similar Documents

Publication Publication Date Title
CN103463500B (en) Medicament for treating cerebral hemorrhage
CN102688383A (en) Traditional Chinese medicine composite for treating body surface ulcer or fester
CN103041250B (en) Pharmaceutical composition for treating tuberculosis
CN101259242B (en) Medicine for treating allergic rhinitis
CN101732638B (en) Chinese medicament for treating pulmonary tuberculosis
CN101721494B (en) Traditional Chinese medicine for treating cervical tuberculous lymphadenitis
CN104206444B (en) A kind of electric liquid device fragrant containing lavender natural and preparation method
CN102727639B (en) External-use medicine for treating venereal disease
CN104887892A (en) Traditional Chinese medicine for treating bacillary dysentery
CN104224905A (en) Chinese herbal medicine for quickly treating nasal diseases
CN104740443A (en) Traditional Chinese medicine compound essential oil
CN102824456A (en) Specific medicine for treating animal aftosa
CN103285290B (en) Chinese medicinal composition for treating ascariasis of biliary tract
CN101129602A (en) Medicament for treating diabetes and nephropathy
CN103041249B (en) Drug for treating tuberculosis
CN103816358A (en) Traditional Chinese medicinal composition for clearing lung and eliminating phlegm
CN104958460A (en) External lotion for treating scabies and preparation method
CN103041248B (en) Medicament for treating tuberculosis
CN103638433B (en) One treats pleuritic pure Chinese medicine composition
CN103977313A (en) Diuresis promoting and itching relieving pills and preparation method thereof
CN102920894B (en) Medicament for treating arthralgia and myalgia and preparation method thereof
CN103845483A (en) Traditional Chinese medicine for treating hepatitis B
CN103372192A (en) Medicament for treating bronchial asthma
CN102114183A (en) Medicament for treating hypertension
CN105169353A (en) Traditional Chinese medicine for treating secretory otitis media

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110601

Termination date: 20130122